FDA's Facebook Slap Gives Drug Industry Little To Like

By Rachel Slajda (March 1, 2013, 6:55 PM EST) -- A recent U.S. Food and Drug Administration warning letter scolding a supplement company for "liking" a Facebook post should remind drug companies to be extremely cautious about their social media activity, experts say, with the FDA clearly on the lookout for behavior that may run afoul of its marketing restrictions even though it has yet to issue formal guidelines.  ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!